Annual FCF
-$2.09 M
+$273.90 K+11.61%
31 December 2022
Summary:
Serina Therapeutics annual free cash flow is currently -$2.09 million, with the most recent change of +$273.90 thousand (+11.61%) on 31 December 2022. During the last 3 years, it has risen by +$273.90 thousand (+11.61%). SER annual FCF is now at all-time high.SER Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.96 M
+$5.04 M+62.98%
30 September 2024
Summary:
Serina Therapeutics quarterly free cash flow is currently -$2.96 million, with the most recent change of +$5.04 million (+62.98%) on 30 September 2024. Over the past year, it has dropped by -$1.82 million (-159.41%). SER quarterly FCF is now -318.19% below its all-time high of -$709.00 thousand, reached on 31 March 2023.SER Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$12.56 M
-$1.82 M-16.96%
30 September 2024
Summary:
Serina Therapeutics TTM free cash flow is currently -$12.56 million, with the most recent change of -$1.82 million (-16.96%) on 30 September 2024. Over the past year, it has dropped by -$10.71 million (-578.46%). SER TTM FCF is now -1672.21% below its all-time high of -$709.00 thousand, reached on 31 March 2023.SER TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SER Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -159.4% | -578.5% |
| 3 y3 years | +11.6% | - | - |
| 5 y5 years | - | - | - |
SER Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +11.6% | -318.2% | +63.0% | -1672.2% | at low |
| 5 y | 5 years | at high | +11.6% | -318.2% | +63.0% | -1672.2% | at low |
| alltime | all time | at high | +11.6% | -318.2% | +63.0% | -1672.2% | at low |
Serina Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.96 M(-63.0%) | -$12.56 M(+17.0%) |
| June 2024 | - | -$8.01 M(+403.4%) | -$10.74 M(+292.9%) |
| Mar 2024 | - | -$1.59 M(+39.2%) | -$2.73 M(+47.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$1.14 M(+61.2%) | -$1.85 M(+161.2%) |
| Mar 2023 | - | -$709.00 K | -$709.00 K |
| Dec 2022 | -$2.09 M(-11.6%) | - | - |
| Dec 2021 | -$2.36 M | - | - |
FAQ
- What is Serina Therapeutics annual free cash flow?
- What is the all time high annual FCF for Serina Therapeutics?
- What is Serina Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Serina Therapeutics?
- What is Serina Therapeutics quarterly FCF year-on-year change?
- What is Serina Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Serina Therapeutics?
- What is Serina Therapeutics TTM FCF year-on-year change?
What is Serina Therapeutics annual free cash flow?
The current annual FCF of SER is -$2.09 M
What is the all time high annual FCF for Serina Therapeutics?
Serina Therapeutics all-time high annual free cash flow is -$2.09 M
What is Serina Therapeutics quarterly free cash flow?
The current quarterly FCF of SER is -$2.96 M
What is the all time high quarterly FCF for Serina Therapeutics?
Serina Therapeutics all-time high quarterly free cash flow is -$709.00 K
What is Serina Therapeutics quarterly FCF year-on-year change?
Over the past year, SER quarterly free cash flow has changed by -$1.82 M (-159.41%)
What is Serina Therapeutics TTM free cash flow?
The current TTM FCF of SER is -$12.56 M
What is the all time high TTM FCF for Serina Therapeutics?
Serina Therapeutics all-time high TTM free cash flow is -$709.00 K
What is Serina Therapeutics TTM FCF year-on-year change?
Over the past year, SER TTM free cash flow has changed by -$10.71 M (-578.46%)